Palo Alto Investors LP - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 120 filers reported holding INSMED INC in Q1 2015. The put-call ratio across all filers is 1.60 and the average weighting 0.2%.

Quarter-by-quarter ownership
Palo Alto Investors LP ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$148,709,648
+19.7%
5,889,4910.0%14.07%
+40.2%
Q2 2023$124,268,260
+23.8%
5,889,4910.0%10.04%
+20.7%
Q1 2023$100,415,822
-14.4%
5,889,491
+0.3%
8.32%
-16.8%
Q4 2022$117,308,394
-6.8%
5,871,291
+0.5%
10.00%
+0.6%
Q3 2022$125,802,000
+9.2%
5,840,3980.0%9.95%
-0.9%
Q2 2022$115,173,000
-16.7%
5,840,398
-0.7%
10.04%
-6.0%
Q1 2022$138,211,000
-15.8%
5,881,299
-2.4%
10.68%
+1.9%
Q4 2021$164,140,000
-1.0%
6,025,706
+0.1%
10.49%
+4.8%
Q3 2021$165,766,000
-3.2%
6,019,1060.0%10.00%
+6.0%
Q2 2021$171,304,000
-13.6%
6,019,106
+3.3%
9.44%
-16.5%
Q1 2021$198,383,000
-2.4%
5,824,507
-4.6%
11.30%
+6.1%
Q4 2020$203,268,000
+4.8%
6,105,980
+1.2%
10.66%
+0.1%
Q3 2020$193,899,000
+17.3%
6,032,956
+0.5%
10.64%
+7.2%
Q2 2020$165,303,000
+70.3%
6,002,289
-0.9%
9.92%
+22.1%
Q1 2020$97,072,000
-40.6%
6,055,623
-11.6%
8.13%
-9.7%
Q4 2019$163,548,000
+28.1%
6,848,760
-5.4%
9.00%
+5.9%
Q3 2019$127,707,000
-36.8%
7,239,649
-8.3%
8.51%
-13.4%
Q2 2019$202,007,000
-9.2%
7,890,917
+3.1%
9.82%
+5.8%
Q1 2019$222,491,000
+121.6%
7,653,6170.0%9.28%
+73.6%
Q4 2018$100,415,000
-32.5%
7,653,617
+4.0%
5.35%
-11.1%
Q3 2018$148,764,000
-13.1%
7,357,283
+1.7%
6.01%
-12.1%
Q2 2018$171,145,000
+6.1%
7,236,583
+1.1%
6.84%
-0.8%
Q1 2018$161,234,000
-19.3%
7,159,590
+11.8%
6.90%
-19.8%
Q4 2017$199,695,000
+3.7%
6,404,586
+3.8%
8.60%
+6.0%
Q3 2017$192,622,000
+99.7%
6,171,816
+9.8%
8.11%
+80.1%
Q2 2017$96,470,000
-0.4%
5,621,816
+1.6%
4.50%
-1.7%
Q1 2017$96,903,000
+34.5%
5,534,150
+1.6%
4.58%
+11.4%
Q4 2016$72,057,000
-2.5%
5,446,516
+7.0%
4.11%
-4.3%
Q3 2016$73,926,000
+48.3%
5,091,298
+0.7%
4.29%
+14.1%
Q2 2016$49,839,000
-17.9%
5,054,713
+5.5%
3.76%
-20.1%
Q1 2016$60,699,000
-30.2%
4,790,8000.0%4.71%
-2.6%
Q4 2015$86,953,000
-1.8%
4,790,800
+0.5%
4.84%
+13.7%
Q3 2015$88,557,000
-23.4%
4,768,800
+0.7%
4.26%
-17.2%
Q2 2015$115,595,000
+19.5%
4,733,601
+1.8%
5.14%
+7.5%
Q1 2015$96,709,000
+35.1%
4,649,448
+0.5%
4.78%
+13.8%
Q4 2014$71,559,000
+40.9%
4,625,648
+18.8%
4.20%
+10.7%
Q3 2014$50,793,000
+164.2%
3,892,199
+304.6%
3.80%
+165.2%
Q2 2014$19,223,000
+59.4%
962,101
+51.9%
1.43%
+186.8%
Q1 2014$12,060,000
+142.8%
633,398
+116.8%
0.50%
+7.8%
Q4 2013$4,967,000
+19.5%
292,199
+9.7%
0.46%
+6.2%
Q3 2013$4,157,000
+30.5%
266,2990.0%0.44%
+16.0%
Q2 2013$3,185,000266,2990.38%
Other shareholders
INSMED INC shareholders Q1 2015
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 1,056,797$33,965,00014.39%
Palo Alto Investors LP 6,032,956$193,899,00010.64%
Sycale Advisors (NY) LLC 360,829$11,597,0009.99%
Burrage Capital Management LLC 165,400$5,316,0004.20%
First Light Asset Management, LLC 1,025,341$32,954,0003.38%
Rubric Capital Management LP 1,100,000$35,354,0003.30%
Sofinnova Investments, Inc. 615,143$19,771,0001.47%
Endurant Capital Management LP 144,313$4,638,0001.37%
Parkwood LLC 70,235$5,514,0000.85%
Novo Holdings A/S 430,107$13,824,0000.69%
View complete list of INSMED INC shareholders